表紙
市場調査レポート

米国の非血管ステント市場

U.S. Markets for Nonvascular Stents

発行 Medtech Insight 商品コード 176182
出版日 ページ情報 英文 140 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=102.18円で換算しております。
Back to Top
米国の非血管ステント市場 U.S. Markets for Nonvascular Stents
出版日: 2011年02月28日 ページ情報: 英文 140 Pages
担当者のコメント
非血管系ステントの市場情報についてかなり詳細に記載しおり、このテーマではこの調査レポートがベストと思います。ミレニアムリサーチ社からも同じテーマで発行されていますので比較してください。メドテックインサイト社では2012年初頭に欧州版の発行を予定しています。
概要

非血管ステントは、循環経路の一時的および慢性的閉塞を緩和し、空気や体液、その他全身の代謝やエネルギー交換のために用いられてきました。米国の非血管ステント処置件数は年率1.5%で増加し、売上は2014年に1億8,920万米ドルになると予測されています。

当レポートは、米国の非血管ステント市場の製品、技術概要、市場の現状と将来予測、競合企業と市場の機会などをまとめ、概略下記の構成でお届けいたします。

エグゼクティブサマリー

第1章 現在および新興の末梢血管および非血管ステント技術

  • ステントデザイン
  • ステントの材料
  • ステントのコーティング

第2章 非血管ステントの臨床的概要

  • ステントの標的となる非血管症状
    • 胆管閉塞
      • 臨床的適応
      • 移植技術
      • 胆管ステントの種類
    • 胃腸管閉塞
      • 結腸直腸ステント
      • 食道ステント
      • 処置件数
    • 肺流出路閉塞
      • 臨床的適応
      • 種類
      • 処置件数
    • 尿路閉塞
      • 尿管閉塞
      • 尿管閉塞
      • 処置件数

第3章 非血管ステント市場

  • 胆管ステントシステム
    • 製品概要
    • 市場予測
    • 競合分析
  • 胃腸管ステントシステム
    • 製品概要
    • 市場予測
    • 競合分析
  • 肺流出路ステントシステム
    • 製品概要
    • 市場予測
    • 競合分析
  • 尿路ステントシステム
    • 尿管ステント製品
    • 尿道ステント製品
    • 市場予測
    • 競合分析

第4章 企業プロファイル

  • AbbeyMoor Medical, Inc.
  • American Medical Systems, Inc.
  • Boston Scientific Corporation
  • Bryan Corporation
  • Cook Group, Inc.
  • Cordis Corporation/Johnson & Johnson
  • Gyrus ACMI/Olympus Corporation
  • Hood Laboratories, Inc.
  • Merit Endotek/Merit Medical Systems, Inc.

付録:企業リスト

目次
Product Code: A255

Nonvascular stenting has been used for decades in the palliation of transient and chronic obstructions of natural circulatory pathways that enable the transfer of air, bodily fluids, and other substances involved in systemic metabolic and energy exchange. These circulatory pathways include the biliary tree as well as the gastrointestinal (GI), pulmonary, and urinary tracts. In 2010, nonvascular stenting systems were used in approximately 516,500 endoluminal recanalization procedures in the U.S., generating an estimated $168.8 million in related sales. Over the forecast period covered by this report, the number of nonvascular stenting procedures in the U.S. is expected to increase at a compound annual rate of 1.5%; during the same period, corresponding dollar sales are expected to increase at a compound annual rate of 2.8%, reaching approximately $189.2 million in the year 2014.

This new report by Medtech Insight includes analyses of products, technologies, current and forecast markets, competitors, and opportunities in the U.S. nonvascular stents market. Major topics covered by this report include a discussion of current and emerging nonvascular stenting technologies; a clinical overview of nonvascular conditions targeted by stenting (e.g., biliary GI, pulmonary, and urinary tract obstruction) and an analysis of the procedure volumes and market forecasts for biliary, GI, pulmonary, and urologic stenting systems in the U.S.

Table of Contents

EXECUTIVE SUMMARY

  • a. Nonvascular Stenting Systems
  • b. Stent Design and Materials
  • c. Products and Procedures
    • i. Biliary Stenting
    • ii. Gastrointestinal Stenting
    • iii. Pulmonary Stenting
    • iv. Urologic Stenting
    • v. Combined Procedure Volumes Forecast
  • d. Market Analysis
    • i. Biliary Stents
    • ii. Gastrointestinal Stents
    • iii. Pulmonary Stents
    • iv. Urologic Stents
    • v. Combined Market Analysis
  • Exhibit ES-1: 2010, Estimated Incidence of Nonvascular Conditions Targeted by Stenting Technologies
  • Exhibit ES-2: Nonvascular Stenting, Procedure Volumes Forecast, 2009-2014
  • Exhibit ES-3: Nonvascular Stenting Systems, Market Forecast, 2009-2014

1. CURRENT AND EMERGING PERIPHERAL VASCULAR AND NONVASCULAR STENTING TECHNOLOGIES

  • 1.1 Stent Design
    • 1.1.1 Vascular Stents
    • 1.1.2 Nonvascular Stents
    • 1.1.3 Stent Deployment Mechanisms
  • 1.2 Stent Materials
    • 1.2.1 Metal Stents
      • 1.2.1.1 Absorbable Magnesium Alloys
      • 1.2.1.2 Cobalt Alloys
      • 1.2.1.3 Nickel-Titanium Alloys
      • 1.2.1.4 Stainless Steel
    • 1.2.2 Standard Polymeric Stents
    • 1.2.3 Biodegradable Polymeric Stents
  • 1.3 Stent Coatings
    • 1.3.1 Radiopacity Enhancement
    • 1.3.2 Biocompatibility Enhancement
    • 1.3.3 Active Therapeutic Enhancement
      • 1.3.3.1 Drug-Eluting Stents
        • 1.3.3.1.1 Antirestenotic Drug-Eluting Stents
        • 1.3.3.1.2 Drug Delivery Techniques
    • 1.3.4 Stent Coverings and Linings
  • Exhibit 1-1: Selected Biomedical, Clinical, and Technical Stent Requirements
  • Exhibit 1-2: Advantages and Disadvantages of Selected Vascular Stent Designs
  • Exhibit 1-3: Advantages and Disadvantages of Metal Stent Materials
  • Exhibit 1-4: Selected Polymeric Stent Materials
  • Exhibit 1-5: Selected Characteristics of Antirestenosis Agents Used in Drug-Eluting Stents
  • Exhibit 1-6: Advantages and Disadvantages of Nonresorbable and Biodegradable Polymeric Drug Carriers for Drug-Eluting Stents

2. CLINICAL OVERVIEW OF NONVASCULAR STENTS

  • 2.1 Nonvascular Conditions Targeted by Stenting
    • 2.1.1 Biliary Tract Obstruction
      • 2.1.1.1 Clinical Indications
      • 2.1.1.2 Implantation Techniques
      • 2.1.1.3 Biliary Stent Types
        • 2.1.1.3.1 Plastic Devices
        • 2.1.1.3.2 Metal Devices
      • 2.1.1.4 Procedure Volumes
    • 2.1.2 Gastrointestinal Tract Obstruction
      • 2.1.2.1 Colorectal Stenting
        • 2.1.2.1.1 Clinical Indications
        • 2.1.2.1.2 Technology
        • 2.1.2.1.3 Implantation Techniques
      • 2.1.2.2 Esophageal Stenting
        • 2.1.2.2.1 Technology
        • 2.1.2.2.2 Implantation Techniques
      • 2.1.2.3 Procedure Volumes
    • 2.1.3 Pulmonary Tract Obstruction
      • 2.1.3.1 Clinical Indications
      • 2.1.3.2 Types of Pulmonary Stenting Systems
      • 2.1.3.3 Procedure Volumes
    • 2.1.4 Urinary Tract Obstruction
      • 2.1.4.1 Ureteral Obstruction
        • 2.1.4.1.1 Urinary Stone Disease
        • 2.1.4.1.2 Ureteral Strictures
        • 2.1.4.1.3 Ureteral Stenting
      • 2.1.4.2 Urethral Obstruction
        • 2.1.4.2.1 Benign Prostatic Hyperplasia
        • 2.1.4.2.2 Urethral Strictures
        • 2.1.4.2.3 Urethral Stenting
      • 2.1.4.3 Procedure Volumes
  • Exhibit 2-1: 2010, Biliary Obstruction, Facts and Figures
  • Exhibit 2-2: Biliary Stenting, Procedure Volumes Forecast, 2009-2014
  • Exhibit 2-3: 2010, Colorectal Obstruction, Facts and Figures
  • Exhibit 2-4: 2010, Esophageal Obstruction, Facts and Figures
  • Exhibit 2-5: Gastrointestinal Stenting, Procedure Volumes Forecast, 2009-2014
  • Exhibit 2-6: 2010, Pulmonary Tract Obstruction, Facts and Figures
  • Exhibit 2-7: Pulmonary Stenting, Procedure Volumes Forecast, 2009-2014
  • Exhibit 2-8: 2010, Upper Urinary Tract Obstruction, Facts and Figures
  • Exhibit 2-9: 2010, Lower Urinary Tract Obstruction, Facts and Figures
  • Exhibit 2-10: Urologic Stenting, Procedure Volumes Forecast, 2009-2014

3. NONVASCULAR STENTS MARKET

  • 3.2.1 Biliary Stenting Systems
    • 3.2.1.1 Products
    • 3.2.1.2 Market Forecast
    • 3.2.1.3 Competitive Analysis
  • 3.2.2 Gastrointestinal Stenting Systems
    • 3.2.2.1 Products
    • 3.2.2.2 Market Forecast
    • 3.2.2.3 Competitive Analysis
  • 3.2.3 Pulmonary Stenting Systems
    • 3.2.3.1 Products
    • 3.2.3.2 Market Forecast
    • 3.2.3.3 Competitive Analysis
  • 3.2.4 Urologic Stenting Systems
    • 3.2.4.1 Ureteral Stenting Products
    • 3.2.4.2 Urethral Stenting Products
    • 3.2.4.3 Market Forecast
    • 3.2.4.4 Competitive Analysis
  • Exhibit 3-1: Nonvascular Stenting, Procedure Volumes Forecast, 2009-2014
  • Exhibit 3-2: Nonvascular Stents, Market Forecast, 2009-2014
  • Exhibit 3-3: 2011, Selected Metal and Plastic Biliary Stents
  • Exhibit 3-4: Biliary Stents, Market Forecast, 2009-2014
  • Exhibit 3-5: 2010, Biliary Stents Market, Share by Supplier
  • Exhibit 3-6: 2011, Selected Colorectal Stents
  • Exhibit 3-7: 2011, Selected Esophageal Stents
  • Exhibit 3-8: Metal Gastrointestinal Stents, Market Forecast, 2009-2014
  • Exhibit 3-9: 2010, Colorectal Stents Market, Share by Supplier
  • Exhibit 3-10: 2010, Metal Esophageal Stents Market, Share by Supplier
  • Exhibit 3-11: 2011, Selected Pulmonary Stents
  • Exhibit 3-12: Pulmonary Stents, Market Forecast, 2009-2014
  • Exhibit 3-13: 2010, Pulmonary Stents Market, Share by Supplier
  • Exhibit 3-14: 2011, Selected Ureteral Stents
  • Exhibit 3-15: 2011, Selected Prostatic Stents
  • Exhibit 3-16: Urologic Stents, Market Forecast, 2009-2014
  • Exhibit 3-17: 2010, Ureteral Stents Market, Share by Supplier
  • Exhibit 3-18: 2010, Urethral Stents Market, Share by Supplier

4. COMPANY PROFILES

  • 4.1 AbbeyMoor Medical, Inc.
  • 4.2 American Medical Systems, Inc.
  • 4.3 Boston Scientific Corporation
  • 4.4 Bryan Corporation
  • 4.5 Cook Group, Inc.
  • 4.6 Cordis Corporation/Johnson & Johnson
  • 4.7 Gyrus ACMI/Olympus Corporation
  • 4.8 Hood Laboratories, Inc.
  • 4.9 Merit Endotek/Merit Medical Systems, Inc.

APPENDIX: COMPANY LISTING

Back to Top